These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1610557)

  • 21. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
    Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
    Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers.
    Olander RM; Wuorimaa T; Käyhty H; Leroy O; Dagan R; Eskola J
    Vaccine; 2001 Nov; 20(3-4):336-41. PubMed ID: 11672895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diphtheria-tetanus-pertussis immunization by intradermal jet injection.
    Stanfield JP; Bracken PM; Waddell KM; Gall D
    Br Med J; 1972 Apr; 2(5807):197-9. PubMed ID: 5022729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents.
    Bégué PC; Grimprel EM; Giovannangeli MD; Abitbol VI
    Pediatr Infect Dis J; 1998 Sep; 17(9):804-9. PubMed ID: 9779766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
    Van Ramshorst JD; Sundaresan TK; Outschoorn AS
    Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.
    Dagan R; Goldblatt D; Maleckar JR; Yaïch M; Eskola J
    Infect Immun; 2004 Sep; 72(9):5383-91. PubMed ID: 15322036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization against neonatal tetanus in New Guinea. 5. Laboratory assayed potency of tetanus toxoids and relationship to human antitoxin response.
    Pittman M; Kolb RW; Barile MF; Hardegree MC; Seligmann EB; Maclennan R; Schofield FD
    Bull World Health Organ; 1970; 43(3):469-78. PubMed ID: 5313001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvanticity of pGPL-Mc and LRS in the immune responses of monkeys to oral immunization with diphtheria and tetanus toxoids.
    Mirchamsy H; Neway T; Hamedi M; Pilet C
    Comp Immunol Microbiol Infect Dis; 1997 Jan; 20(1):13-20. PubMed ID: 9023036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Bryla DA; Robbins JB
    J Pediatr; 1997 Apr; 130(4):532-6. PubMed ID: 9108848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    Biologicals; 1991 Jan; 19(1):23-9. PubMed ID: 2049173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
    Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive haemagglutination tests using purified antigens covalently coupled to turkey erythrocytes.
    Relyveld EH; Huet M; Lery L
    Dev Biol Stand; 1996; 86():225-41. PubMed ID: 8785953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR; Gottshall RY; Nelsom E; Angela F
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III.
    Aggerbeck H; Wantzin J; Heron I
    Vaccine; 1996 Sep; 14(13):1265-72. PubMed ID: 8961516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.
    Huang LM; Lee CY; Lin TY; Chen JM; Lee PI; Hsu CY
    Vaccine; 1996 Jun; 14(9):916-22. PubMed ID: 8843635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.
    Halperin SA; Smith B; Russell M; Scheifele D; Mills E; Hasselback P; Pim C; Meekison W; Parker R; Lavigne P; Barreto L
    Pediatr Infect Dis J; 2000 Apr; 19(4):276-83. PubMed ID: 10783014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.